BioSpace News Archive

Theravance Biopharma Announces Tender Offer For Up To $95 Million Of Its Ordinary Shares

Theravance Biopharma, Inc. announced a “modified Dutch auction” tender offer to purchase up to $95 million of its ordinary shares, par value $0.00001 per share.

September 28, 2022
·
7 min read
FDA

Celltrion USA Receives U.S. FDA Approval for its Oncology Biosimilar Vegzelma® (bevacizumab-adcd) for the Treatment of Six Types of Cancer

Celltrion USA announced that the U.S. Food and Drug Administration has approved Vegzelma®, a biosimilar to Avastin®, for the treatment of six types of cancer.

September 28, 2022
·
9 min read
Policy

Kurin, Inc. Announces Successful FDA Audit

Kurin, Inc., the inventor and manufacturer of the Kurin® blood culture collection sets, announced the results of their recent FDA inspection.

September 28, 2022
·
1 min read
Business

Spectrum Chemical Appoints Russell Kneipp as President and CEO, Names Randy Burg Co-Chairman

Spectrum Chemical Mfg. Corp., a leading global provider of fine chemicals, laboratory equipment and supplies, announced the promotion of Russell Kneipp to President and Chief Executive Officer, effective immediately.

September 28, 2022
·
3 min read
Pharm Country

Ocugen Announces Agreement With Washington University in St. Louis for Commercialization of Intranasal COVID-19 Vaccine in U.S., Europe, and Japan

Ocugen, Inc. announced that the company has entered into an exclusive license agreement with Washington University in St. Louis, MO for the rights to develop, manufacture and commercialize its proprietary, intranasally delivered COVID-19 vaccine in the United States, Europe, and Japan.

September 28, 2022
·
4 min read
Biotech Beach

Emmaus Life Sciences Announces Collaboration with Kier (Junior) Spates to Share Personal Experience with Sickle Cell Disease and Endari®

Emmaus Life Sciences, Inc. announced a collaboration with the Steve Harvey Morning Show cast member Kier Spates to share Mr. Spates’ personal experience with the use of Endari®, Emmaus’ prescription L-glutamine oral powder, to treat his sickle cell disease, or SCD.

September 28, 2022
·
4 min read
Portfolio Highlights: Clinical and Financial Updates of ABM, F5, AceLink, HAYA, Regenacy, and Arthrosi

As the investment division of Viva Biotech, Viva BioInnovator is committed to being a collaborative platform for Innovative Biotech companies from around the world.

September 28, 2022
·
7 min read
BioMidwest

Zomedica To Present at Dawson James Securities 7th Annual Small Cap Growth Conference

Zomedica Corp. announced that Larry Heaton, Zomedica’s Chief Executive Officer, is scheduled to provide a company overview and its prospects for growth at the Dawson James Securities Small Cap Growth Conference on October 12, 2022 at the Wyndham Grand Hotel in Jupiter, Florida.

September 28, 2022
·
1 min read
Mallinckrodt Announces Submission of 510(k) to the U.S. FDA for Inhaled Nitric Oxide Delivery System

Mallinckrodt plc today announced the submission of a 510(k) premarket notification application to the U.S. Food and Drug Administration (FDA) for an investigational inhaled nitric oxide delivery system for INOmax® (nitric oxide) gas, for inhalation.

September 28, 2022
·
6 min read
Bio NC

Asensus Surgical Announces St. Bernhard Hospital in Germany to Initiate Senhance Surgery ProgramSystem to be Utilized by the Oncology-Focused Clinic for General and Visceral Surgery

Asensus Surgical, Inc. today announced the Clinic for General and Visceral Surgery at the St. Bernhard Hospital in Kamp-Lintfort, Germany has entered into an agreement to lease and utilize a Senhance® Surgical System.

September 28, 2022
·
5 min read